Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combinations of Didanosine (DDI), Zidovudine (ZDV) and Nevirapine (NVP) can reduce CSF HIV-1 viral load in pediatric patients with advanced HIV disease

Combinations of Didanosine (DDI), Zidovudine (ZDV) and Nevirapine (NVP) can reduce CSF HIV-1 viral load in pediatric patients with advanced HIV disease. 12th World AIDS Conference. 1998; Geneva.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.